Dr. Anna C. Juncadella, MD

Dr. Juncadella practices at NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System.

Dr. Juncadella's NPI, 1467714980, was assigned on June 11, 2012. Dr. Juncadella graduated from University of Miami, Miller School of Medicine in 2012. Dr. Juncadella holds Florida license ME136594.

Dr. Juncadella's primary practice is NCH Baker Hospital, at 350 7th St N, Naples, FL 34102 in Collier County. The practice phone is (239) 624-5000.

Dr. Juncadella's primary practice is NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System. Dr. Juncadella is also affiliated with Physicians Regional Medical Center - Pine Ridge. The medical group on file is NCH Medical Group - Hospitalists.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Juncadella practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Juncadella's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Juncadella is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Juncadella's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal or bowel obstruction among the conditions Dr. Juncadella treats.

CMS data shows 1,268 Medicare services from Dr. Juncadella across 14 procedure codes in 2024, for 622 Medicare patients. Medicare paid $125,892 for them.

CMS counts 622 Medicare patients who saw Dr. Juncadella in 2024. The largest group is 65 to 74, with 327 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Juncadella's median patient age at 64, with 73% women.

In 2024, Dr. Juncadella wrote 1,001 Medicare Part D claims for 348 patients. 81% of them were for generic drugs. CMS names the drug for 867 of them, across 22 drugs with 11 or more claims each, at $1,124,035 in total drug cost. In 2023, CMS named 508 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Juncadella for performance year 2024, reported through an alternative payment model (APM). Dr. Juncadella accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 214 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Juncadella, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Juncadella, published from 2015 to 2021. The most frequent topics are Adalimumab, Inflammatory Bowel Diseases and Remission Induction. Dr. Juncadella's most frequent co-authors are Adam S. Cheifetz, MD, Joseph D. Feuerstein, MD and Sandeep Singh Sekhon, MD.

CMS Open Payments shows 49 general payments to Dr. Juncadella from 18 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 50% of the total. AMAG Pharmaceuticals, Inc. paid the most, $2,215.

Dr. Juncadella graduated from University of Miami, Miller School of Medicine in 2012.

Dr. Juncadella is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.